On October 22, 2024, we acquired privately-held Opus Genetics Inc., a clinical-stage gene therapy company focused on IRDs, in ...

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

further loss of T cell function, both which culminate in recrudescence and disease. Simon, Bugos and colleagues report the design and characterization of monospecific and bispecific synthetic ...

Key details of Wealth Guard are: Covering a loss in value of up to 20% of net initial ... be no more than 0.5% plus VAT per annum of the value of each portfolio at that date. The above illustration ...

According to veteran trader Kenny Polcari, letting emotions interfere with decisions is "a recipe for disaster." ...

The John Hancock Freedom 529 Portfolio recorded a low single-digit loss for the quarter and modestly trailed its blended ...

S&P 500 companies lost a combined $2.4 trillion in stock market value in Thursday's selloff on Wall Street, their biggest one ...

If an investor has a net portfolio loss, then firstly it's important to look at the current holdings,” says Amit Jain, Co- ...

Return data from 1926 to 2021. Portfolio Mix Average Annual Return Best Year Worst Year Years with a Loss 100% bonds 6.3% 45.5% (8.1%) 20 out of 96 80% bonds and 20% stocks 7.5% 40.7% (10.1% ...

“My portfolio has been drastically down almost 20%. Most of my loss-making companies are recent IPO listings, including SMEs as well. I honestly think Sebi (Securities and Exchange Board of ...

has rejected suggestions that its dual mandate to provide a commercial return for its clients and its social mandate in law potentially contributed to it making losses in its unlisted portfolio.

Two of the world’s top hedge funds have been hit by losses since the turn of the year amid market turmoil over President Trump’s tariff plans that look set to upend global trade. Ken Griffin ...